Dr Reddys Laboratories (RDY) EPS (Basic) Growth (1y) (2010 - 2021)
Dr Reddys Laboratories (RDY) EPS (Basic) Growth (1y) (2010 - 2021) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.98 Bn | 39.32 Bn | 2.15 Bn | -301.82% |
| 3 | Zoetis | 31.53 Bn | 29.86 Bn | 1.05 Bn | 1.21% |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | -17.09% |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn | 13.91% |
| 6 | Viatris | 18.74 Bn | 17.85 Bn | 1.46 Bn | -2,504.14% |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn | 31.67% |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 388.06% |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.95 Bn | - | - |
| 10 | Alkermes | 8.12 Bn | 7.46 Bn | 397.90 Mn | -99.41% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2021 | -10.11% |
| Mar 31, 2021 | -2.58% |
| Sep 30, 2020 | -35.13% |
| Jun 30, 2020 | -2.52% |
| Mar 31, 2020 | -15.88% |
| Sep 30, 2019 | -214.24% |
| Jun 30, 2019 | 121.65% |
| Mar 31, 2019 | 49.14% |
| Dec 31, 2018 | 43.88% |
| Sep 30, 2018 | 37.92% |
| Dec 31, 2017 | -6.19% |
| Sep 30, 2017 | -38.60% |
| Dec 31, 2016 | -38.55% |
| Sep 30, 2016 | -3.54% |
| Dec 31, 2015 | -6.17% |
| Sep 30, 2015 | -10.35% |
| Dec 31, 2014 | -12.60% |
| Sep 30, 2014 | -1.98% |
| Mar 31, 2014 | 50.58% |
| Dec 31, 2013 | -9.67% |